Fellowship · Sylmar, CA
Sponsored by Olive View/UCLA Medical Center
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture method.
Nature biotechnology · 2025 · 88 citations · Sarah M. Larson
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2026 · 26 citations · Sarah M. Larson
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 137 citations · Sarah M. Larson
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study.
Blood · 2025 · 51 citations · Sarah M. Larson
NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 174 citations · Sarah M. Larson
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025.
Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 44 citations · Sarah M. Larson
Estimation of prevalence of autoimmune diseases in the United States using electronic health record data.
The Journal of clinical investigation · 2024 · 60 citations · Ingrid He
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.
Cancer discovery · 2023 · 95 citations · Sarah M. Larson